Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gay trader is back, LOL, short restriction tomorrow
Looks like things are picking up
New 13G out, slow grind up.
Avexis bought out by Novartis, running IBB UP, IMO
Around 2 has been the loading zone for a while now. Move coming when u least expect it. This tootsie roll is gonna get lit up sooner than later. GLTA
WOW, i just got out of this 3-weeks ago. I really thought it was a good one too. Sorry longs
IBB hitting 52-week lows
That was typo LMFAO stanly not stanky
Good news out, sounds like stanky is gonna be really informative, to include NANO and RSV
They are having a paper published by peers, maybe that will be done.
I agree, shorties tried play games in premarket, the really tried to pull it under 2, but to no avail. They gonna have to shit or get off of the pot, news is coming soon on the 4TH, GLTA AND HAPPY EASTER, even u shorties, see you guys next week.
RSI sitting @ 48, the pump is primed to run. Could very possibly run up into conference next week.
The bid is stacking up, hopefully this tootsie roll gets lit up, and we see a squeeze, GLTA
I agree, let’s roll
Data should b published by peers soon, that should give us a little boost.
Nice read gipper
Not illegal @ all, an offering is @ their discretion, nobody can make them. The only person that should be sued on this deal is the coke head fund manager that put out his BS report
They pulled the offering, looks like shorts are toast, karma is about to deliver them some justice. GL LONGS
I’ve been there, LOL
Yeah seen that too
Luckily I pulled the trigger and bought around lunch today. :)
WOW nice AH
Agreed
Thay have always announced when ER was, but still nothing from the company
Call me crazy, I’m still holding.95’S
Thanks INM
Where are u seeing that?
FS, churn baby churn
Read my post on trizzino, very interesting
??
http://novavax.com/page/15/partners
Looks like Gates increased funding, more than doubled it.
Earning beat, news out
Mr. John Joseph Trizzino, B.S., M.B.A. has been an Senior Vice President of Commercial Operations at Novavax, Inc. since March 2014. Mr. Trizzino served as the Chief Executive Officer of ImmunoVaccine Inc., from September 2011 to August 31, 2013. Mr. Trizzino served as Senior Vice President of Business Development at Novavax, Inc. from March 2010 to September 21, 2011. He served as Senior Vice President of International & Government Alliances at Novavax Inc., from July 2009 to March 2010. He served as Vice President of Trade and Distribution of MedImmune Inc., since April 2006 and served as its Vice President of the vaccine franchise. He was responsible for developing and implementing strategies for distribution of MedImmune's current and future products. He was also responsible for managing relationships with wholesalers and distributors. Mr. Trizzino served as Senior Vice President of business development at ID Biomedical Corp. since July 2004. During his tenure at ID Biomedical, he negotiated its $2.3 billion U.S. influenza vaccine distribution agreement and was responsible for government relations in addition to his business development duties. Previously, he worked for Henry Schein's medical group for eight years in roles of increasing responsibility, including Vice President of business development and Vice President and General Manager of General Injectables and Vaccines. Mr. Trizzino has more than 28 years of experience in the vaccine industry and has worked closely with public and private partners including the U.S. Centers for Disease Control and Prevention, the Department of Health and Human Services and various vaccine distributors. He has managed a number of important flu vaccine products, including FluMist and Fluviral (Flulaval by GSK), created profitable global marketing partnerships. He served as a Director of ImmunoVaccine Inc. from September 26, 2011 to August 31, 2013. He works with the CDC and Influenza Summit and his work as a Healthcare Distribution Management Association (HDMA) Board member. Mr. Trizzino holds a Bachelor of Science degree from the C.W. Post Campus, Long Island University and a Master's in Business Administration from the New York University's Leonard N. Stern School of Business.
IMG_0333.PNG
All good, churn baby churn
They are blowing out stops before it goes higher.
All good, welcome to biotech.